Literature DB >> 9605729

Reversible segmental cerebral arterial vasospasm and cerebral infarction: possible association with excessive use of sumatriptan and Midrin.

J F Meschia1, M D Malkoff, J Biller.   

Abstract

OBJECTIVE: To describe a patient who developed reversible segmental cerebral arterial vasospasm and cerebral infarction while taking excessive amounts of sumatriptan succinate and a combination drug (Midrin) consisting of isometheptene mucate, 65 mg, dichloralphenazone, 100 mg, and acetaminophen, 325 mg.
DESIGN: Case report.
SETTING: Tertiary care center. PATIENT: A 43-year-old man who developed a left occipital infarct after taking a total of 23 sumatriptan succinate tablets (25 mg per tablet) and 32 Midrin tablets during a 7-day period and who on digital subtraction angiography was shown to have segmental cerebral arterial narrowing in multiple vessels. An extensive evaluation for other possible risk factors for cerebral infarction was unrevealing. MAIN OUTCOME AND
RESULTS: Discontinuation of sumatriptan and Midrin regimens and administration of nicardipine hydrochloride led to nearly total resolution of the angiographic findings, and the patient had no recurrent strokes.
CONCLUSIONS: One should consider the diagnosis of drug-induced vasospasm in patients with cerebral infarction and a history of excessive use of sumatriptan and Midrin. The initial angiographic abnormalities may resemble those found in patients with primary angiitis of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605729     DOI: 10.1001/archneur.55.5.712

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

1.  Benign cerebral angiopathy; postpartum cerebral angiopathy: characteristics and treatment.

Authors:  Sofia Calado; Miguel Viana-Baptista
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

2.  [Pregnancy-linked endotheliopathy. A disease with multiple variants?].

Authors:  F Sextro; S Klimpe; G F Hamann
Journal:  Nervenarzt       Date:  2012-04       Impact factor: 1.214

3.  Postpartum angiopathy and other cerebral vasoconstriction syndromes.

Authors:  Aneesh B Singhal; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

4.  Reversible cerebral vasoconstriction syndromes.

Authors:  Richard A Bernstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

Review 5.  The risk of stroke in patients with migraine and implications for migraine management.

Authors:  Gretchen E Tietjen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Call-Fleming syndrome associated with subarachnoid haemorrhage: three new cases.

Authors:  R R Moustafa; C M C Allen; J-C Baron
Journal:  BMJ Case Rep       Date:  2009-02-02

Review 7.  Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course.

Authors:  T R Miller; R Shivashankar; M Mossa-Basha; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-15       Impact factor: 3.825

Review 8.  Systematic review of reversible cerebral vasoconstriction syndrome.

Authors:  Ahsan Sattar; Georgios Manousakis; Matthew B Jensen
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-10

Review 9.  Reversible Cerebral Vasoconstriction Syndrome: Recognition and Treatment.

Authors:  Cecilia Cappelen-Smith; Zeljka Calic; Dennis Cordato
Journal:  Curr Treat Options Neurol       Date:  2017-06       Impact factor: 3.598

10.  Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage.

Authors:  Brian L Edlow; Scott E Kasner; Robert W Hurst; John B Weigele; Joshua M Levine
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.